Aquestive Therapeutics Inc Stock Ownership - Who owns Aquestive Therapeutics?

Insider buying vs selling

Have Aquestive Therapeutics Inc insiders been buying or selling?
Alexander Mark SchobelChief InnovationTech Officer2024-03-1550,000$6.00
Stephen WargackiSVP Research Development2024-03-101,687$4.88
Cassie JungSVP Operations2024-03-101,132$4.88
Cassie JungSVP Operations2024-03-098,300$4.88
Alexander Mark SchobelChief InnovationTech Officer2024-03-095,895$4.88
A. Ernest Toth Jr.SVP Chief Financial Officer2024-03-0911,705$4.88
Stephen WargackiSVP Research Development2024-03-0911,269$4.88
Daniel BarberPresident and CEO2024-03-0937,938$4.88
Peter E. BoydSVP Information Technology Human Resources and Communications2024-03-098,370$4.88
Lori J. BraenderSVP General Counsel2024-03-0910,530$4.88

1 of 2

AQST insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AQST insiders and whales buy or sell their stock.

AQST Shareholders

What type of owners hold Aquestive Therapeutics Inc stock?
Bratton Capital Management LP10.78%9,810,958$26.78MInstitution
Vr Adviser LLC6.10%5,555,555$15.17MInstitution
Vanguard Group Inc3.56%3,242,571$8.85MInstitution
Franklin Resources Inc2.44%2,220,000$6.06MInstitution
Douglas K. Bratton2.15%1,961,163$5.35MInsider
Laurion Capital Management LP1.70%1,545,300$4.22MInstitution
Renaissance Technologies LLC1.51%1,375,800$3.76MInstitution
Blackrock Inc1.48%1,344,876$3.67MInstitution
Monashee Investment Management LLC1.10%1,000,000$2.73MInstitution
Alexander Mark Schobel1.08%984,476$2.69MInsider

1 of 3

AQST vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AQST45.58%7.49%Net Selling
EBS42.29%57.71%Net SellingNet Selling

Aquestive Therapeutics Stock Ownership FAQ

Who owns Aquestive Therapeutics?

Aquestive Therapeutics (NASDAQ: AQST) is owned by 45.58% institutional shareholders, 7.49% Aquestive Therapeutics insiders, and 46.93% retail investors. Douglas K. Bratton is the largest individual Aquestive Therapeutics shareholder, owning 1.96M shares representing 2.15% of the company. Douglas K. Bratton's Aquestive Therapeutics shares are currently valued at $5.26M.

If you're new to stock investing, here's how to buy Aquestive Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.